The results demonstrated that CTLs activated by DC vaccines loaded with MUC1 antigen peptides exhibited potent cytotoxic activity against all three pancreatic cancer cell lines (Figures 5A–C), with increasing cytotoxicity in a dose-dependent manner. This evidence concerns the gene MUC1 and pancreatic neoplasm.